EKSO Q4 2022 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M-12.9% YoY

Gross Profit

$2M47.3% margin

Operating Income

-$4M-124.9% margin

Net Income

-$3M-89.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$967,000

Balance Sheet

Total Assets

$41M

Total Liabilities

$15M

Stockholders' Equity

$25M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-12.9%
Gross Profit	$2M	$2M	-30.5%
Operating Income	-$4M	-$5M	+2.5%
Net Income	-$3M	-$3M	-11.0%

Revenue Segments

EksoHealth

$3M98%

EksoWorks

$54,0002%

Geographic Segments

Americas

$2M23%

UNITED STATES

$2M23%

EMEA

$1M20%

EMEA, Other

$1M19%

GERMANY

$515,0007%

Asia Pacific

$439,0006%

Americas, Other

$3,0000%